OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
What is the latest Operating Profit of OXYGENTA PHARMACEUTICAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹-9.70 Cr |
| Mar2024 | ₹-7.12 Cr |
| Mar2023 | ₹147,599 Cr |
| Mar2022 | ₹3.84 Cr |
| Mar2021 | ₹-7.87 Cr |
How is Operating Profit of OXYGENTA PHARMACEUTICAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.70 Cr | Negative | |
| Mar2024 | ₹-7.12 Cr | Negative | |
| Mar2023 | ₹147,599 Cr | 3,841,628.53 | |
| Mar2022 | ₹3.84 Cr | Positive | |
| Mar2021 | ₹-7.87 Cr | - | |
Compare Operating Profit of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹177.5 Cr | -0.4% | -3.8% | -61.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.4% |
-3.8% |
-61.6% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses